These in vitro results were translated in the corresponding in vivo model of cis-Pt-resistant A549/DX xenografts, where the co-administration of the MRP1-mediated sensitizers F397 and F421 with cis-Pt greatly reduced tumor growth, with no signs of toxicity. The gene discussed is ABCC1; the disease is neoplasm.